Arcturus Therapeutics Ltd. Stock-Based Compensation
Arcturus Therapeutics Ltd. reported Stock-Based Compensation of $399.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2019-05-13
- Arcturus Therapeutics Ltd. share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $399.00K, a 1434.62% increase year-over-year.
- Arcturus Therapeutics Ltd. share-based payment arrangement, noncash expense for the quarter ending 2018-12-31 was $506.00K, a 64.29% increase year-over-year.
- Arcturus Therapeutics Ltd. share-based payment arrangement, noncash expense for the quarter ending 2018-09-30 was $587.00K, a 67.76% decline year-over-year.
- Arcturus Therapeutics Ltd. share-based payment arrangement, noncash expense for the quarter ending 2018-06-30 was $140.00K.
- Arcturus Therapeutics Ltd. share-based payment arrangement, noncash expense for fiscal 2018 was $1.26M, a 41.98% decline from fiscal 2017.
- Arcturus Therapeutics Ltd. share-based payment arrangement, noncash expense for fiscal 2017 was $2.17M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 71 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | $399.00K 10-Q · filed 2019-05-13 | $905.00K derived: sum of 2 quarters · filed 2019-05-13 | $1.49M derived: sum of 3 quarters · filed 2019-05-13 | $1.63M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-12-31 | $506.00K derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $1.09M derived: sum of 2 quarters · filed 2019-03-18 | $1.23M derived: sum of 3 quarters · filed 2019-03-18 | $1.26M 10-K · filed 2019-03-18 | ||
| 2018-09-30 | $587.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $727.00K derived: sum of 2 quarters · filed 2018-11-07 | $753.00K 6-K · filed 2018-11-07 | $1.06M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-06-30 | $140.00K derived: 6-K 6 month − 10-Q 3 month · filed 2018-09-28 | $166.00K 6-K · filed 2018-09-28 | $474.00K derived: sum of 3 quarters · filed 2019-05-13 | $2.29M derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2018-03-31 | $26.00K 10-Q · filed 2019-05-13 | $334.00K derived: sum of 2 quarters · filed 2019-05-13 | $2.15M derived: sum of 3 quarters · filed 2019-05-13 | |||
| 2017-12-31 | $308.00K derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $2.13M derived: sum of 2 quarters · filed 2019-03-18 | $2.17M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $1.82M derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $1.86M 6-K · filed 2018-11-07 | ||||
| 2017-06-30 | $41.00K 6-K · filed 2018-09-28 | |||||
| 2016-12-31 | $300.00K 20-F · filed 2018-05-14 | $2.50M 20-F · filed 2017-04-28 | ||||
| 2015-12-31 | $99.00K 20-F · filed 2018-05-14 | $2.37M 20-F · filed 2016-03-04 | ||||
| 2014-12-31 | $4.09M 20-F · filed 2017-04-28 | |||||
| 2013-12-31 | $1.54M 20-F · filed 2016-03-04 | $3.76M 20-F · filed 2014-03-28 | ||||
| 2012-12-31 | $26.00K 20-F · filed 2015-02-27 | |||||
| 2011-12-31 | $1.55M 20-F · filed 2014-03-28 |